profile
Virofanatics


HuanXuan, Gurinder, Atikah, Sandra Pharmaceutical Sciences Microbology B PS0903


Our Blog
Check Us Out!


archives
gone with the wind

January 2010
February 2010
you're on your way

your links go here,
credits 1
credits 2
credits 3
credits 4
link
link
link

table of contents
RNA VIRUS

HIV & AIDS

DENGUE VIRUS

VIRAL REPLICATION

HEPATITIS C

H1N1(swine flu)

RHINOVIRUS

METHODS OF STUDYING VIRUSES

CLASSIFICATION OF VIRUSES


Designer
Colours / Headers
Icon
Virofanatics.blogspot.com
INTRODUCTION--This Blog is about Viruses. Our topics are on Methods of studying viruses, RNA virus, H1N1, Hepatitis C, examples of different viruses such as HIV & AIDS,dengue virus, H1N1.

RNA VIRUS
Tuesday, February 2, 2010
chikungunya virus (RNA virus)




Chikungnya involved an African virus (RNA virus) and an Asian mosquito, which reflecting the globalization of vectorborne diseases. The Aisan mosquito involved, is none other than Aedes mosquito.



Chikungnya's symptoms are similar to dengue fever: fever, joints pain and the tendency of bleeding.
The incubation period of Chikungunya disease is from 2 to 4 days. [4]

Then, patients will have fever up to 39 ℃ (102.2 ℉), red spots or rashes of the trunk and occasionally the limbs, and arthralgia (joint pain) or arthritis (inflammation of the joints) affecting multiple joints. [5, 6] - Acute Phase

Other nonspecific symptoms can include headache, conjunctival injection, and slight photophobia.

Typically, the fever lasts for 2 days and then ends abruptly (dengue fever has longer period of fever).

Patients have complained of joint pains for much longer time periods depending on their age. [5, 6] - Chronic phase (not all patients will have it)


The management of the disease
includes rest, fluids and medications to relieve symptoms of fever and pain, such as ibuprofen, naproxen and paracetamol. Aspirin should be avoided (may cause refractory arthritis).


(back to the top.)


HIV & AIDS
Sunday, January 31, 2010
This video shows how HIV becomes AIDS.








HIV



AIDS


(back to the top.)


AIDS

What is HIV and AIDS?

HIV stands for Human Immunodeficiency Virus. HIV is a virus that takes over certain immune system cells to make many copies of itself. HIV causes slow but constant damage to the immune system.

AIDS stands for Acquired Immune Deficiency Syndrome. AIDS is the condition diagnosed when there are a group of related symptoms that are caused by severe HIV infection. AIDS makes the body vulnerable to life-threatening illnesses called opportunistic infections.

How does HIV affect the body?

Normally, the human immune system is the body’s protection against bacterias, viruses, etc.; it is like a coat of armor. When HIV enters the body, it starts poking holes in the armor. Eventually, the armor becomes very weak and unable to protect the body. Once the armor is very weak or is gone, the person is said to have AIDS. An AIDS diagnosis is generally made when either the body's protective T-cells drop below a certain level, or the HIV-positive individual begins to experience opportunistic infections. An opportunistic infection is an infection that would not normally affect an otherwise healthy person. Oftentimes, it's these infections that are the cause of illness or death in HIV-positive individuals - not the virus itself. If people do not get any treatment for HIV disease, it takes an average of 8-10 years to progress from HIV to AIDS.

How is HIV transmitted?

HIV is transmitted through four body fluids: blood, semen, vaginal fluid, and breast milk. In order to pass HIV from one person to another, HIV-infected fluid from one person needs to get into the bloodstream of another person. HIV is usually transmitted through sharing needles, unprotected anal, vaginal, and sometimes oral sex, and from mother to infant before or during delivery or while breastfeeding.

**Special Note for HIV-Positive Mothers:

In developed countries like the U.S., formula feeding is strongly recommended over breastfeeding for babies of HIV-positive mothers. Whether choosing breastfeeding or formula, there should be little or no switching between the two, as doing so could put the child at a higher risk of contracting HIV, since baby formula can be harsh and weaken the lining of a baby's stomach, giving a path for HIV to enter the baby's bloodstream.

How can I prevent myself from contracting HIV?

Becoming educated about HIV and understanding how it is transmitted is the first, and perhaps most important way to prevent the spread of HIV. It is essential for people to make informed decisions about the level of risk they are willing to take, based on what is realistic for them.

Abstaining from sex and needle sharing is the most effective way for people to protect themselves from HIV and other sexually transmitted diseases. However, abstinence is not a realistic option for everyone.

Safer Sex

When abstinence is not an option, the proper use of barrier protection such as latex or polyurethane condoms (male or female), with a water based lubricant*, is the next best thing for vaginal or anal sex.




(back to the top.)


Dengue virus
Saturday, January 30, 2010
DENGUE VIRUS

The Dengue virus is a member of the virus family Flaviviridae and is transmitted to people through the bite of the mosquitos Aedes aegypti and Aedes albopictus. Dengue virus is now believed to be the most common arthropod-borne disease in the world. Dengue is mainly found in the tropics because the mosquitoes require a warm climate. A major fear of epidemiologists is that the mosquitoes will develop resistance to cooler climates and then be able to infect people in the United States and other temperate climates. The virus is transmitted when a mosquito of the Aedes genus bites an individual infected with dengue virus. The virus in the blood of the infected individual then infects the mosquito and travels from the mosquito's stomach to its salivary glands were the virus multiplies. The virus is then injected into another person when the mosquito injects anticoagulants that prevent blood clotting when the mosquito is feeding. The mosquito remains able to transmit dengue for its entire life.



The dengue virus has a unusually smooth surface than ohter viruses

Each year, 100 million people become infected with dengue virus. People first reported the existence of dengue-like disease in 1779 but it was most likely present long before in first appeared in literature. However, the majority of deaths that result from dengue infection result from Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). People who develop DHF have a 5% chance of death but if they go on to develop DSS then the mortality rate can rise as high as 40%.


SYMPTOMS OF DENGUE VIRUS

The incubation period of dengue fever is approximately four days. The person will come down with fever and present a discrete macular or maculopapular rash. It is difficult to distinguish dengue fever from other viral diseases and the person usually recovers in 5 days. In more severe cases, fever and rash are accompanied by headache, retroorbital pain, myalgia, backache, sore throat, and abdominal pain. The patients become lethargic and experience anorexia and nausea.

DHF has a similar incubation period as dengue fever and many of the same symptoms. However, the fever is more severe and the drowsiness and lethagry is more extreme. The patient has increased vascular permeablilty and abnormal hemostasis. This can cause the individual to lose blood volume, result in hypotension, go into shock (DSS) and die.

It is important to understand why an individual will develop DHF/DSS. The Dengue virus has been shown to have 4 subtypes. These 4 subtypes are different strains of dengue virus that have 60-80% homology between each other. The major difference for humans lies in subtle differences in the surface proteins of the different dengue subtypes. After a person is infected with dengue, they develop an immune response to that dengue subtype. The immune response produced specific antibodies to that subtype's surface proteins that prevents the virus from binding to macrophage cells (the target cell that dengue viruses infect) and gaining entry. However, if another subtype of dengue virus infects the individual, the virus will activate the immune system to attack it as if it was the first subtype. The immune system is tricked because the 4 subtypes have very similar surface antigens. The antibodies bind to the surface proteins but do not inactivate the virus. The immune response attracts numerous macrophages, which the virus proceeds to infect because it has not been inactivated. This situation is referred to as Antibody-Dependent Enhancement (ADE) of a viral infection. This makes the viral infection much more acute. The body releases cytokines that cause the endothelial tissue to become permeable which results in hemorrhagic fever and fluid loss from the blood vessels.


TREATMENT

The most important aspect in treatment of DHF is to prevent further fluid loss. Drugs such as corticosteroids or carbazochrome sodium sulfonate are given to stabilize capillary permeability and avoid plasma leakage. As regards to prevention, a vaccine has proven rather difficult to produce. The reason for this stems from the 4 subtypes of dengue. If an individual develops immunity to one subtype and then tries to launch an immune response to another subtype then they will develop DHF/DSS. Work has been done on a tetravalent vaccine that will attempt to give the individual immunity to all four of the subtypes at the same time. Currently, the most effective prevention measures lie in mosquito control.There is no vaccine to prevent dengue.

Avoid mosquito bites when travelling in tropical areas:
• Use mosquito repellents on skin and clothing.
• When outdoors during times that mosquitoes are biting, wear long-sleeved shirts and long pants tucked into socks.
• Avoid heavily populated residential areas.
• When indoors, stay in air-conditioned or screened areas. Use bednets if sleeping areas are not screened or air-conditioned.
• If you have symptoms of dengue, report your travel history to your doctor.

Eliminate mosquito breeding sites in areas where dengue might occur:

• Eliminate mosquito breeding sites around homes. Discard items that can collect rain or run-off water, especially old tires.
• Regularly change the water in outdoor bird baths and pet and animal water containers.





(back to the top.)


HIV
Wednesday, January 27, 2010
HIV REPLICATION AND LIFE CYCLE


(back to the top.)


Viral Replication
Viral Replication



An HIV virus attaching to a host cell





Coronaviruses being absorbed into a host cell. The plasma membrane is budding inward, and will release the viruses inside the cell




Hepatitis A virus reproducing inside a cell



Electron micrograph of a respiratory syncytial virus (RSV) in in the process of budding at the cell membrane



A liver cell killed by infection with the hepatitis C virus


(back to the top.)


HEPATITIS C

what is hepatitis C?

There are at least six viruses known to cause liver disease: hepatitis A, B, C, D, E, and G, which vary in their severity and characteristics. Hepatitis C can lead to serious, permanent liver damage, and in many cases, death.

As a result, most Hepatitis C infections (80-90%) become chronic and lead to liver disease, including cirrhosis (scarring of the liver tissues) and liver failure. Hepatitis C infection is typically mild in its early stages, and it is rarely recognized until it has caused significant damage to the liver. The cycle of disease from infection to significant liver damage can take 20 years or more.

Blood transfusions account for nearly 10% of all cases of Hepatitis C. Prior to 1990, there were no tests for hepatitis C in donated blood, and the risk of infection was between 8 and 10%. Since 1993, risk has been negligible.


The Hepatitis C Epidemic

Hepatitis C is a one of a special set of viruses, called RNA viruses, which can outmanuever the human immune system. They do this by mutating rapidly, often evolving faster than the immune system can develop an effective response to them. Infections by RNA viruses like Hepatitis C are hard to beat—and can be very dangerous.


(back to the top.)


The H1N1 Swine Flu: A Look Inside
Tuesday, January 26, 2010

H1N1 virus. On how it started.



(back to the top.)


H1N1(Swine Flu)
Sunday, January 24, 2010
Influenza A (H1N1) was initially called ‘swine flu’ as it was found to be similar to influenza viruses that affect pigs. Scientists later found that the virus was an assortment of genes which were of avian, human and swine origin and quite different from what they believed it to be.

In June 2009, the WHO declared Influenza A (H1N1) a global pandemic. This new strain now exists in many communities all over the world.

As this is a new strain of virus, most people will not have resistance, and it can potentially spread quickly and infect a large proportion of the population in a short period of time.

While the drugs Tamiflu® and Relenza® can be used to treat a H1N1 infection, there is currently no vaccine available.

Causes

Human-to-human transmission of Influenza A (H1N1) has been occurring all over the world. Flu can be spread when a person coughs, sneezes or speaks. The flu viruses are transmitted into the air through droplets that can be inhaled by many other people. When these viruses enter the nose, throat or lungs of an infected person, they begin to multiply, causing symptoms of flu.

Influenza A (H1N1) infection is highly contagious. People with an infection may be able to spread the flu virus a day before the symptoms appear and throughout the period that he/she is ill.


Symptoms of Influenza A(H1N1)

Just like the seasonal flu, Influenza A (H1N1) infection in humans can vary in severity from mild to severe. Signs and symptoms of infection may include the following:

  • High fever (Temperature > 38°C)
  • Cough
  • Muscle pains
  • Sore throat
  • Fatigue or tiredness
  • Headache
  • Nausea
  • Vomiting or diarrhea


See your family doctor if you have any of the above symptoms.

Most cases of Influenza A (H1N1) are mild and self-limiting and patients recover. However, there are several groups of individuals are at high-risk of developing complications from this strain. These high-risk groups include:

  • Persons aged 65 years and older
  • Children under five years of age
  • Those with chronic metabolic disease (including diabetes mellitus), chronic pulmonary or heart disease
  • Those with medical conditions such as cancer on active treatment, on organ transplant dialysis, or immunosuppression (including immunosuppression caused by medications or by HIV)
  • Children and teenagers less than 18 years who are receiving long-term aspirin therapy
  • Pregnant women


If you are pregnant, undergoing cancer treatment or dialysis you should consult your primary care specialist. All other groups should go to a Pandemic Preparedness Clinic (PPC), polyclinic or their primary care doctor.

Call 995 if you experience the following warning signs or if your symptoms worsen:

  • Difficulty in breathing or chest pain
  • Purple or blue discolouration of the lips
  • Severe and persistent vomiting
  • Deterioration of symptoms since the onset of illness
  • Flu-like symptoms improve but then return with fever and worse cough
  • Signs of dehydration such as dizziness when standing, the absence of urination of lack of tears when children cry
  • Fits
  • Loss of appetite
  • Less responsive than normal, drowsy or becomes more confused

Treatment of Influenza A(H1N1)

Anti-Viral Drugs
There are anti-viral medications available to treat people who are infected. Anti-viral medications such as Tamiflu® or Relenza® fight against the influenza viruses from reproducing in the body.

These medications, when taken early in the course of infection (within 2 days of the appearance of symptoms) may:

  • Reduce the severity of the infection with faster recovery from the illness.
  • Prevent serious flu complications.

In most cases, laboratory testing to confirm infection with Influenza A (H1N1) is not needed before starting treatment. Doctors will exercise clinical judgement in prescribing anti-viral drugs on a case-by-case basis taking into account of patient’s risk of developing influenza-related complications, prevalence of infection in the community and the risks and benefits of treatment. As with any other medications, there are potential side-effects related to the use of Tamiflu.

Vaccinations
The current seasonal flu vaccine gives little (if any) protection against the new Influenza A (H1N1) strain. There is no vaccine available for this new strain of H1N1 virus yet. Vaccine manufacturers are currently in the process of producing and testing a vaccine for this new strain.


Prevention

Since the illness occurs through direct contact with infectious material and respiratory secretions, it is important to practice good personal hygiene. Take these everyday steps to protect your health:

Cover Your Nose and Mouth

  • With a tissue when you cough or sneeze and dispose the tissue properly in the trash after use.

Wash Your Hands

  • Regularly and thoroughly with soap and water
  • Before and after preparing food
  • After going to the toilet
  • Before and after eating
  • After blowing your nose
  • After using your hand when coughing or sneezing

Contain the Spread of Flu

  • Use a serving spoon when sharing food from a common dish.
  • Do not share personal items such as toothbrushes and towels.
  • Avoid touching your eyes, nose or mouth.
  • Consider wearing a mask and avoid crowded places if you are in a high-risk group.
  • Stay at home and do not go to work or school if ill.
  • Head to your nearest Pandemic Preparedness Clinic (PPC) if you have flu like symptoms.

Build Up Your Immunity

  • If you are a smoker, quit smoking. It harms you and your family.
  • Take more fruit and vegetables. Fruit and vegetables are the most power-packed combination of nutrients your body needs for good health.
  • Drink the equivalent of 8 glasses of fluid daily.
  • Engage in 30 minutes of moderate intensity physical activity on 5 or more days a week.
  • Learn to relax and rest.

Keep Your Environment Clean

  • Do not throw leftover food on the floor or in the open.
  • Do not leave food in common areas for stray animals.
  • Do not spit on the floor and common areas.
  • Throw used masks, tissue or litter into rubbish bins.

If you are living with someone who is infected

  • Observe good personal hygiene.
  • Do not have meals together with the ill person as masks have to be removed during meals.
  • Wear a surgical mask and remain at a distance of at least 2 metres from one another if you need to communicate with the ill person.
  • Maintain good ventilation at home (e.g. keeping windows open in toilets, kitchens and rooms)
  • Be socially responsible by limiting contact with someone outside your household. When you need to go out, consider wearing a mask and avoid crowded places.

If you are looking after someone who is infected

  • Wear a surgical mask.
  • Clean your hands with soap and water (or an alcohol-based hand rub) after you have touched the infected person, soiled linens or laundry.
  • Be alert and call for help when the infected person’s symptoms deteriorate of if the symptoms worsen.
  • If you are pregnant you should not be looking after someone who is infected as you are at increased risk of flu-related complications.


(back to the top.)


Methods of studying viruses
Wednesday, January 20, 2010
1)physical methods(xray crystallography,electron microscopy,ultracentrifugation)

2)Serological/Immunological methods(Haemagglutination,Haemagglutination Inhibition,Immunoblot or western blot,ELISA)

3)Molecular Biotechnology(Polymerase Chain Reaction,DNA sequencing,Southern blot,Northern blot)



What is an ELISA test?

An ELISA test uses components of the immune system and chemicals to detect immune responses in the body (for example, to infectious microbes). The ELISA test involves an enzyme (a protein that catalyzes a biochemical reaction). It also involves an antibody or antigen (immunologic molecules).

What is the use of an ELISA test?

ELISA tests are widely utilized to detect substances that have antigenic properties, primarily proteins (as opposed to small molecules and ions such as glucose and potassium). The substances detected by ELISA tests include hormones, bacterial antigens and antibodies.

How does an ELISA test work?

There are variations of the ELISA test, but the most basic type consists of an antibody attached to a solid surface. This antibody has affinity for (will latch on to) the substance of interest, for example, human chorionic gonadotropin (HCG), the commonly measured protein which indicates pregnancy. A mixture of purified HCG linked (coupled) to an enzyme and the test sample (blood, urine, etc) are added to the test system. If no HCG is present in the test sample, then only HCG with linked enzyme will bind. The more HCG which is present in the test sample, the less enzyme linked HCG will bind. The substance the enzyme acts on is then added, and the amount of product measured in some way, such as a change in color of the solution.

What are the advantages of ELISA?

ELISA tests are generally relatively accurate tests. They are considered highly sensitive and specific and compare favorably with other methods used to detect substances in the body, such as radioimmune assay (RIA) tests. They have the added advantages of not needing radioisotopes (radioactive substances) or a costly radiation counter (a radiation-counting apparatus).

types of ELISA:

indirect ELISA
sandwich ELISA(also known as antibody-antigen reaction)
reverse ELISA
competitive ELISA

Most common type of ELISA is the antibody-antigen



(back to the top.)


classifications of viruses
Monday, January 18, 2010

BACKGROUND INFORMATION

Viruses are infectious agents with both living and nonliving characteristics.

1. Living characteristics of viruses

a. They reproduce at a fantastic rate, but only in living host cells.

b. They can mutate.

2. Nonliving characteristics of viruses

a. They are acellular, that is, they contain no cytoplasm or cellular organelles.

b. They carry out no metabolism on their own and must replicate using the host cell's metabolic machinery. In other words, viruses don't grow and divide. Instead, new viral components are synthesized and assembled within the infected host cell.

c. The vast majority of viruses possess either DNA or RNA but not both.



Baltimore classification


Class I: Double stranded DNA viruses


Class II: Single stranded DNA viruses


Class III: Double stranded RNA viruses


Class IV & V: Single stranded RNA viruses


Class IV: Single stranded RNA viruses - Positive (+) sense


Class V: Single stranded RNA viruses - Negative (-) sense


Class VI: Positive (+) sense single stranded RNA viruses that replicate through a DNA intermediate


Class VII: Double stranded DNA viruses that replicate though a single stranded RNA intermedia


ICTV CLASSIFICATION

International committee on Taxonomy of Viruses

order(-virales)

family
(-viridae)
Subfamily (-virinae)

genus
(-virus)
species
(-virus)

LHT System of Virus Classification
  • Phylum Vira (divided into 2 subphyla)
  • Subphylum Deoxyvira (DNA viruses)
  • Class Deoxybinala (dual symmetry)
  • Order Urovirales
  • Family Phagoviridae
  • Class Deoxyhelica (Helical symmetry)
  • Order Chitovirales
  • Family Poxviridae
  • Class Deoxycubica (cubical symmetry)
  • Order Peplovirales
  • Family Herpesviridae (162 capsomeres)
  • Order Haplovirales (no envelope)
  • Family Iridoviridae (812 capsomeres)
  • Family Adenoviridae (252 capsomeres)
  • Family Papiloviridae (72 capsomeres)
  • Family Paroviridae (32 capsomeres)
  • Family Microviridae (12 capsomeres)
  • Subphylum Ribovira (RNA viruses)
  • Class Ribocubica
  • Order Togovirales
  • Family Arboviridae
  • Order Lymovirales
  • Family Napoviridae
  • Family Reoviridae
  • Class Ribohelica
  • Order Sagovirales
  • Family Stomataviridae
  • Family Paramyxoviridae
  • Family Myxoviridae
  • Order Rbadovirales
  • Suborder Flexiviridales
  • Family Mesoviridae
  • Family Peptoviridae
  • Suborder Rigidovirales
  • Family Pachyviridae
  • Family Protoviridae
  • Family Polichoviridae


(back to the top.)